There were no significant differences in sCD163/sTWEAK ratio between SSc patients receiving different therapies or between those with and without arterial hypertension (data not shown), nor any other significant associations between treatments received by SSc patients or the presence of arterial hypertension and sCD163/sTWEAK ratio (Table 2). The gene discussed is CD163; the disease is systemic sclerosis.